Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 7/20 | 0.62 |
| ▸ | MIF | P14174 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 6/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | MAOB | P27338 | 2/20 | 0.62 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.59 |
| ▸ | PGR | P06401 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | GLA | P06280 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Coumarin SCHEMBL28308230 | 0.90 | RAB9A (0.62) | NPC1MIFRAB9AKDM4EALDH1A1 | |
| SCHEMBL2687082 | 0.88 | SLC16A3 (0.51) | NPC1MIFRAB9AKDM4EALDH1A1 | |
| SCHEMBL194256 | 0.85 | CYP19A1 (0.79) | NPC1MIFRAB9AKDM4EALDH1A1 | |
| SCHEMBL4307998 | 0.85 | SLC16A3 (0.52) | NPC1MIFRAB9AKDM4EALDH1A1 | |
| SCHEMBL14160789 | 0.85 | NPC1 (0.58) | NPC1MIFRAB9AKDM4EALDH1A1 | |
| SCHEMBL4300702 | 0.84 | ACHE (0.50) | NPC1MIFRAB9AKDM4EALDH1A1 | |
| SCHEMBL15216064 | 0.84 | ALDH1A1 (0.69) | NPC1RAB9AKDM4EALDH1A1MAOB | |
| Bromide SCHEMBL4299197 | 0.83 | SLC16A3 (0.51) | NPC1MIFRAB9AKDM4EALDH1A1 | |
| Bromide SCHEMBL4309541 | 0.83 | ALDH1A1 (0.50) | NPC1MIFRAB9AKDM4EALDH1A1 | |
| SCHEMBL5590725 | 0.82 | MIF (0.58) | NPC1MIFRAB9AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | claimed |
| CN-107652222-B | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2021-09-10 | — | — | CN | claimed |
| US-10919909-B2 | Photoinitiated reactions | LINTFIELD LIMITED (GB) | 2021-02-16 | — | — | US | claimed |
| CN-105198793-B | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2019-08-13 | — | — | CN | claimed |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | LINTFIELD LIMITED (GB) | 2019-07-11 | — | — | US | claimed |
| US-20190046463-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | ICURE PHARMACEUTICAL INC. (KR) | 2019-02-14 | — | — | US | claimed |
| EP-3415141-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | Icure Pharmaceutical Inc. (KR) | 2018-12-19 | — | — | EP | claimed |
| CN-104284888-B | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2017-10-27 | — | — | CN | claimed |
| EP-4743828-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2026-05-20 | — | — | EP | disclosed |
| US-20250149336-A1 | PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-05-08 | — | — | US | disclosed |
| CN-114129544-B | Ultraviolet curable hydrogel resin for transdermal administration, hydrogel, and cataplasm comprising same | Icure药品株式会社 | 2025-03-21 | — | — | CN | disclosed |
| CN-119403840-A | Photocurable composition, method for producing cured film, solid-state imaging element, image display device, and radical polymerization initiator | 富士胶片株式会社 | 2025-02-07 | — | — | CN | disclosed |
| WO-2025011754-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2025-01-16 | — | — | WO | disclosed |
| EP-4114825-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2024-11-20 | — | — | EP | disclosed |
| WO-2002100903-A1 | OXIME ESTER PHOTOINITIATORS HAVING A COMBINED STRUCTURE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-12-19 | — | — | WO | disclosed |
| US-20020020832-A1 | Photosensitive resin composition | CIBA SPECIALTY CHEMICALS CORP. | 2002-02-21 | — | — | US | disclosed |
| EP-1163553-A1 | OXIME DERIVATIVES AND THE USE THEREOF AS PHOTOINITIATORS | Ciba SC Holding AG (CH) | 2001-12-19 | — | — | EP | disclosed |
| US-20010012596-A1 | For resist applications; thermostability, storage stability | CIBA SPECIALTY CHEMICALS CORP. | 2001-08-09 | — | — | US | disclosed |
| WO-2000052530-A1 | OXIME DERIVATIVES AND THE USE THEREOF AS PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-09-08 | — | — | WO | disclosed |
| US-4250053-A | WITH FLUORESCENT COMPOUND | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1981-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919909-B2 | Photoinitiated reactions | KMO, DECR1, PPOX | NPC1 2000/4885MIF 4651/4885RAB9A 3269/4885 |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | DOHH, PAH, DBH | NPC1 2594/4885MIF 4053/4885RAB9A 4138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.